跳至主要内容
临床试验/JPRN-UMIN000005337
JPRN-UMIN000005337已完成未知

The effect on the renal functions and blood pressure of DPP-4 Inhibitor for the type 2 diabetic patients . - Sitagliptin therapy for blood glucose ,BP,and renal function in type 2 diabetic patients.(STABAR)

Kanazawa Medical University Diadetes & Endocrinology0 个研究点目标入组 100 人开始时间: 2011年3月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with type 1 diabetes 2)History of severe ketosis, diabetic coma or precoma within 6 months 3)Patients with severe infections, before or after operation, or with serious trauma 4)Ptientswho are pregnant, breast-feeding and/or intention to become pregnant 5)Patients with the severe renal impairment 6)Patients receiving Alfa-glycosidase inhibitor, Glinide or Insulin 7)Patients receiving DPP-4 inhibitor other than Sitagliptin 8)Patients having allergies against DPP-4 inhibitor or alfa-Glycosidase inhibitor 9)Patients determined to be inappropriate for the study by physician based on the scientific grounds.

研究者

发起方
Kanazawa Medical University Diadetes & Endocrinology

相似试验

The effect on the renal functions and blood pressure... | 临床试验